Argenica Therapeutics Limited (ASX:AGN)
Australia
· Delayed Price · Currency is AUD 0.175
-0.005 (-2.78%)
Apr 29, 2026, 4:10 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 22.48 million as of April 29, 2026. Its market cap has decreased by -76.76% in one year.
Market Cap
22.48M
Enterprise Value
17.44M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 22.48M, an increase of 18.16%. That is a compound annual growth rate of 3.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 23.12M | -38.98% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Algorae Pharmaceuticals | 22.25M |
| Noxopharm | 23.35M |
| Patrys | 17.13M |
| Neurotech International | 17.13M |
| EZZ Life Science Holdings | 35.54M |
| NeuroScientific Biopharmaceuticals | 38.25M |
| Avecho Biotechnology | 40.41M |
| Cambium Bio | 11.62M |